1. Al-Daghri, N. M., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Shaik, N. A., Draz, H. M., et al. (2010). Gender-specific associations between insulin resistance, hypertension, and markers of inflammation among adult Saudis with and without diabetes mellitus type 2. Advances in Medical Sciences, 55(2), 179–185.
2. Anty, R., Bekri, S., Luciani, N., Saint-Paul, M. C., Dahman, M., Iannelli, A., et al. (2006). The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH. American Journal of Gastroenterology, 101(8), 1824–1833.
3. Bouma, M., Rutten, G. E., de Grauw, W. J., Wiersma, T., & Goudswaard, A. N. (2006). Nederlands Huisartsen Genootschap. Summary of the practice guideline ‘Diabetes mellitus type 2’ (second revision) from the Dutch College of General Practitioners. [Article in Dutch]. Nederlands Tijdschrift voor Geneeskunde, 150(41), 2251–2256.
4. Browning, L. M., Hsieh, S. D., & Ashwell, M. (2010). A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutrition Research Reviews, 23(2), 247–269.
5. Caan, B., Armstrong, M. A., Selby, J. V., Sadler, M., Folsom, A. R., Jacobs, D., et al. (1994). Changes in measurements of body fat distribution accompanying weight change. International Journal of Obesity and Related Metabolic Disorders, 18(6), 397–404.